Anto Biosciences
Last verified 2026-09-25. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $500,000attributed |
|---|---|
| Latest round | seed, $1.0M, 2025-09-01attributed |
| Founded | 2025 |
| Headquarters | San Francisco, USA |
| Industry | healthtech |
| Stage | seed |
| Website | anto.bio |
Anto builds AI models that make the gut microbiome computable by removing noise from microbial data through sparsification algorithms. The platform targets pharmaceutical companies developing drugs, since microbiome composition influences medication efficacy and safety. It pioneers quality-aware sparsification that extracts predictive signal.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-09-01 | seed | $1.0M | undisclosed |
Detected tech stack
Cloudflare, Webflow, jquery 3.5.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Seed, $1.0M | attributed | yc named as publisher. No document URL on file. |
| Total raised $500,000 | attributed | yc named as publisher. No document URL on file. |
| Company existence | sourced | Y Combinator named as publisher. Document, retrieved 2026-09-17. |
| Description | self-reported | anto.bio, read 2026-09-25 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-24Existence: self-reported → sourced, Y Combinator, document, retrieved 2026-09-17 | Existence | self-reported → sourced | Y Combinator, document, retrieved 2026-09-17 |
Records begin 2026-09-24. All changes